PDCD1 and cancer: The IPA unveiled the significant activation of immune‐related signaling such as crosstalk between dendritic cells and natural killer cells, natural killer cell signaling, Th1, and Th2 Pathway, and PD‐1/PD‐L1 cancer immunotherapy pathway in the comparison between primary GC and OM (Figure 2B).